Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,300.00
0.00 (0.00%)
At close: Jul 20, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 36.14 billion as of July 21, 2026. Its market cap has decreased by -7.21% in one year.
Market Cap
36.14B
Enterprise Value
25.28B
Revenue
36.27B
Ranking
n/a
PE Ratio
5.31
Stock Price
5,300.00
ChartMarket Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 36.14B, a decrease of -24.06%. That is a compound annual growth rate of -4.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 36.14B | -23.72% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 159.30B |
| JW Shinyak | 112.86B |
| CG MedTech | 106.36B |
| Sewoon Medical | 96.32B |
| OSTEONIC | 91.48B |
| SCL Science | 54.53B |
| MEDYSSEY Co.,Ltd | 37.56B |
| KM Corporation | 31.92B |